2025-12-19 - Analysis Report
Here's a breakdown of Tempus AI (TEM) based on the provided data:

**0) Simple Numbers & Analysis**

*   **Return:** TEM's cumulative return is 11.05% compared to the S&P 500 (VOO)'s 28.31%.
*   **Price:** Current price is $62.21, a decrease from the previous close of $64.615.
*   **Moving Averages:** 5-day SMA = 66.843, 20-day SMA = 72.926, 60-day SMA = 80.3397
*   **Indicators:** RSI = 12.66 (oversold), PPO = -1.4225, MRI = 0.7 (Medium Investment).
*   **Analyst Consensus:** Buy rating with an average target price of $90.17.

**1) Return Rate Comparison (TEM vs. VOO)**

*   **Company Overview:** Tempus AI Inc. is a company focused on precision medicine through data and AI.
*   **Divergence:** TEM is underperforming the S&P 500 (VOO). The divergence is currently -7.5.
*   **Relative Divergence:** The relative divergence is 28.8, indicating it is in the lower range of recent fluctuations.
*   **Alpha, Beta Analysis:**

    *   **CAGR (2023-2025):** 11.0% suggests moderate growth.
    *   **MDD (2023-2025):** 76.7% indicates very high risk.
    *   **Alpha (2023-2025):** -16.0% shows underperformance relative to its risk (Beta).
    *   **Beta (2023-2025):** 0.3 suggests the stock is less volatile than the market.
    *   **Cap(B):** $11.1 billion market capitalization.

    *Analysis:* While showing moderate growth, the high MDD and negative Alpha indicate significant risk and underperformance relative to the market. The low Beta suggests the stock is relatively less sensitive to overall market movements.

**2) Recent Stock Price Fluctuations**

*   **Price:** $62.21, a decrease from the previous close of $64.615, change: -3.72%.
*   **Moving Averages:** The stock price is below all three moving averages (5-day, 20-day, and 60-day), which is generally considered a bearish signal.
*   **Analysis:** The stock price is trending downwards. The last market change shows a sharp decline.

**3) Analysis of Indicators**

*   **MRI:** A value of 0.7 indicates a "Medium Investment" recommendation based on market risk.
*   **RSI:** An RSI of 12.66 suggests the stock is heavily oversold, potentially indicating a possible rebound.
*   **PPO:** A PPO of -1.4225 suggests the stock is in a downtrend, but the magnitude is relatively small.
*   **Hybrid Signal:** The signal recommends allocating 100% of cash to buy 14 shares, considering the stock "Very Safe" with an MRI of 0.9. It also suggests a monthly investment of 5% of total investment, implying a long-term investment strategy.
*   **Recent Divergence Change:** The negative change of -11.0 indicates a short-term downward trend relative to its comparison.
*   **Price Change:** The price change of -3.72 indicates a sharp decline. Investors should consider the reasons behind this fluctuation.
*   **Expected Return:** The missing Expected Return data is a significant gap in the analysis.

**4) Recent News & Significant Events**

*   **[2025-12-18]** EVP Erik Phelps Sells Shares: This could create negative sentiment, though it is only one individual's transaction.
*   **[2025-12-18]** Seeking Alpha Article: "Healthcare Hyper-Growth Opportunity For The Risk Tolerant": This is a positive article highlighting the potential of Tempus AI.
*   **[2025-11-25]** Quiver Quantitative: Focuses on FDA Clearance and Earnings Report. These are key events influencing investor sentiment.
*   **[2025-11-24]** Yahoo Finance: TEM vs. BFLY: This type of comparison helps investors understand TEM's relative strengths and weaknesses within the health tech sector.
*   **[2025-12-02]** Simply Wall St: FDA Clearance for AI Diagnostics: FDA clearance is a major catalyst for companies in this space, as indicated.
*   **[2025-12-18]** Benzinga: Top 3 Health Care Stocks You'll Regret Missing This Quarter: Inclusion in such a list is generally positive.

**4-2) Analyst Opinions**

*   **Consensus:** "Buy" rating indicates that analysts generally believe the stock will perform well.
*   **Target Price:** The average target price ($90.17) suggests substantial upside potential from the current price ($62.21).

**5) Comprehensive Analysis**

*   **Summary:** Tempus AI (TEM) is a company with high growth potential, as seen from Analyst Opinions, but also carries significant risk, indicated by the high MDD and recent underperformance. The stock is currently in a downtrend, trading below its moving averages, and the RSI suggests it is oversold. Recent news is mixed, with positive articles balanced by an executive share sale.
*   **Investment Considerations:**
    *   **Potential Upside:** Analyst target prices and articles highlighting hyper-growth potential suggest significant upside.
    *   **Risks:** High MDD, negative Alpha, recent price declines, and the executive share sale are all warning signs. The lack of an expected return makes it hard to estimate long-term value.
    *   **FDA Clearance:** FDA clearance acts as a major positive catalyst for the company, and earnings report.
*   **Overall:** TEM appears to be a high-risk, high-reward investment. Investors should carefully weigh their risk tolerance and conduct further due diligence before investing. The positive analyst consensus suggests some confidence in the company's long-term prospects, but the recent negative price action and insider selling warrant caution. The Hybrid Signal implies that it is a good entry point for long-term investors with an allocation of 100% cash for a very safe trade.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.